pSivida Corp. (PSDV) - Medical Equipment - Deals and Alliances Profile

Date: July 18, 2014
Pages: 37
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P97B960A583EN
Leaflet:

Download PDF Leaflet

pSivida Corp. (PSDV) - Medical Equipment - Deals and Alliances Profile
Summary

pSivida Corp. (pSivida) is a drug researcher and developer. The company provides miniaturized and sustained-release drug delivery products. Its products include Iluvien, Retisert and Durasert/Latanoprost. The company’s Durasert is a miniaturized, injectable; sustained-release drug delivery system is used for the treatment of chronic diseases of the back of the eye. pSivida’s Iluvien is an injectable, non-erodible, intravitreal implant for the treatment of DME. Its Retisert is an intravitreal drug implant for the treatment of chronic non-infectious posterior uveitis. The company partners with Pfizer, Alimera Sciences and Bausch & Lomb. pSivida is headquartered in Watertown, Massachusetts, the US.

pSivida Corp. (PSDV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
pSivida Corp., Medical Equipment, Deals By Year, 2008 to YTD 2014
pSivida Corp., Medical Equipment Deals By Type, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals By Region, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals By Market, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals Summary, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deal Details
Partnerships
pSivida Amends Licensing Agreement With Pfizer
Equity Offering
pSivida Raises USD7 Million in Private Placement of Shares
pSivida Announces Private Placement Of Shares For US$19 Million
pSivida Completes Public Offering Of Shares For US$10.8 Million
pSivida Completes Private Placement Of Units For US$5.4 Million
pSivida Completes Registered Direct Offering Of Units For US$11 Million
pSivida Files Registration Statement For Public Offering Of US$42 Million
pSivida Corp. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
May 13, 2014: pSivida Reports Third Quarter 2014 Results
Feb 07, 2014: pSivida Reports Second Quarter 2014 Results
Nov 12, 2013: pSivida Reports First Quarter 2014 Results
Nov 05, 2013: pSivida Corp Announces First Quarter 2014 Financial Results Release Date and Conference Call Information
Sep 25, 2013: pSivida Reports Fourth Quarter and Fiscal Year 2013 Results
Sep 18, 2013: pSivida Announces Fourth Quarter and Fiscal Year 2013 Financial Results Release Date and Conference Call Information
May 13, 2013: pSivida Reports Q3 Fiscal 2013 Results
Feb 06, 2013: psivida Reports Q2 Fiscal 2013 Results
Government and Public Interest
Dec 04, 2013: pSivida Executives to Present at Two Upcoming Investor Conferences This Month
Sep 27, 2013: pSivida to Present at 4th Annual Conference on Biosimilars & Biobetters
Sep 04, 2013: pSivida to Present At Two Investment Conferences in September
Product News
Dec 02, 2013: U.K.'s NICE Issues Final Guidance Recommending Alimera Sciences' ILUVIEN
Sep 30, 2013: pSivida to Present at 4th Annual Conference on Biosimilars & Biobetters
Jul 11, 2013: pSivida Corp. Announces Interim Data From Investigator-Sponsored Uveitis Study
Jul 01, 2013: pSivida Corp. Announces Initiation of Phase III Clinical Trial in Posterior Uveitis
Jun 14, 2013: Alimera Sciences Announces Issuance Of Positive Appraisal Recommendation On Iluvien For Consultation In UK
May 08, 2013: Alimera Sciences Secures $20m Debt Facility
May 07, 2013: pSivida Announces Commercial Launch Of Iluvien In Germany With First Patient Treated
Apr 01, 2013: pSivida Reports On Resubmission To FDA Of NDA For Iluvien For Chronic Diabetic Macular Edema
Mar 22, 2013: pSivida Reports Updates On Iluvien For Planned Resubmission To FDA And European Launch
Jan 23, 2013: Alimera Sciences's Iluvien Receives Final Published Guidance From NICE
Jan 17, 2013: Alimera Sciences Receives Marketing Authorization In Spain For Iluvien To Treat Chronic Diabetic Macular Edema
Product Approvals
Jan 17, 2013: Alimera Sciences Receives Marketing Authorization In Spain For Iluvien To Treat Chronic Diabetic Macular Edema
Clinical Trials
Jul 11, 2013: pSivida Corp. Announces Interim Data From Investigator-Sponsored Uveitis Study
Jul 01, 2013: pSivida Corp. Announces Initiation of Phase III Clinical Trial in Posterior Uveitis
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

pSivida Corp., Medical Equipment, Key Facts, 2013
pSivida Corp., Medical Equipment, Deals By Year, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals By Region, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals By Market, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals Summary, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals By Year, 2008 to YTD 2014
pSivida Corp., Medical Equipment Deals By Type, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals By Region, 2008 to YTD 2014
pSivida Corp., Deals By Market, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals Summary, 2008 to YTD 2014
pSivida Amends Licensing Agreement With Pfizer
pSivida Raises USD7 Million in Private Placement of Shares
pSivida Announces Private Placement Of Shares For US$19 Million
pSivida Completes Public Offering Of Shares For US$10.8 Million
pSivida Completes Private Placement Of Units For US$5.4 Million
pSivida Completes Registered Direct Offering Of Units For US$11 Million
pSivida Files Registration Statement For Public Offering Of US$42 Million
pSivida Corp., Key Competitors
pSivida Corp., Key Employees
pSivida Corp., Other Locations
pSivida Corp., Subsidiaries

LIST OF FIGURES

pSivida Corp., Medical Equipment, Deals by Type, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals By Year, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals by Type, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals By Region, 2008 to YTD 2014
pSivida Corp., Medical Equipment, Deals by Market, 2008 to YTD 2014
Skip to top


Ask Your Question

pSivida Corp. (PSDV) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: